Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6582)
All Articles published online
|
Publishing Process of This Article
|
Oct 14, 2013 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Choi DH, Lee SJ, Kang CD, Park MO, Choi DW, Kim TS, Lee W, Cho BR, Kim YH, Lee BK, Ryu DR, Lee JW. Nonalcoholic fatty liver disease is associated with coronary artery disease in Koreans. World J Gastroenterol 2013; 19(38): 6453-6457 [PMID: 24151364 DOI: 10.3748/wjg.v19.i38.6453] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i38/6453.htm |
| Number | Citing Articles |
| 1 |
Yang Liu, Lin-Lin Lu, De-Xi Yuan, Ning Geng, Shi-Ying Xuan, Yong-Ning Xin. AGTR1 rs3772622 gene polymorphism increase the risk of nonalcoholic fatty liver disease patients suffer coronary artery disease in Northern Chinese Han population. Lipids in Health and Disease 2016; 15(1) doi: 10.1186/s12944-016-0279-3
|
| 2 |
Yaowu Zou, Xinde Li, Can Wang, Jing Wang, Fei Wang, Lidan Ma, Wenjun You, Changgui Li. Association between non‐alcoholic fatty liver disease and peripheral artery disease in patients with type 2 diabetes. Internal Medicine Journal 2017; 47(10): 1147 doi: 10.1111/imj.13549
|
| 3 |
Stefano Ballestri, Claudio Tana, Maria Di Girolamo, Maria Cristina Fontana, Mariano Capitelli, Amedeo Lonardo, Giorgio Cioni. Semi-Quantitative Ultrasonographic Evaluation of NAFLD. Current Pharmaceutical Design 2020; 26(32): 3915 doi: 10.2174/1381612826666200417142444
|
| 4 |
Luan Rodrigues Abdallah, Ricardo Cardoso de Matos, Yves Pacheco Dias March e Souza, Débora Vieira-Soares, Gabriela Muller-Machado, Priscila Pollo-Flores. Non-alcoholic Fatty Liver Disease and Its Links with Inflammation and Atherosclerosis. Current Atherosclerosis Reports 2020; 22(1) doi: 10.1007/s11883-020-0820-8
|
| 5 |
Alessandro Mantovani, Stefano Ballestri, Amedeo Lonardo, Giovanni Targher. Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease. Digestive Diseases and Sciences 2016; 61(5): 1246 doi: 10.1007/s10620-016-4040-6
|
| 6 |
Jong Man Kim, Sang Yun Ha, Jae-Won Joh, Dong Hyun Sinn, Woo Kyung Jeong, Gyu-Seong Choi, Geum Youn Gwak, Choon Hyuck David Kwon, Young Kon Kim, Yong Han Paik, Joon Hyeok Lee, Won Jae Lee, Suk-Koo Lee, Cheol Keun Park. Predicting Hepatic Steatosis in Living Liver Donors via Noninvasive Methods. Medicine 2016; 95(7): e2718 doi: 10.1097/MD.0000000000002718
|
| 7 |
Min Kyung Kim, Chul Woo Ahn, Ji Sun Nam, Shinae Kang MD, Jong Suk Park, Kyung Rae Kim. Association between nonalcoholic fatty liver disease and coronary artery calcification in postmenopausal women. Menopause 2015; 22(12): 1323 doi: 10.1097/GME.0000000000000503
|
| 8 |
Shunquan Wu, Fuquan Wu, Yingying Ding, Jun Hou, Jingfeng Bi, Zheng Zhang. Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: A systematic review and meta-analysis. Scientific Reports 2016; 6(1) doi: 10.1038/srep33386
|
| 9 |
Stefano Ballestri, Dante Romagnoli, Fabio Nascimbeni, Giampiero Francica, Amedeo Lonardo. Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications. Expert Review of Gastroenterology & Hepatology 2015; 9(5): 603 doi: 10.1586/17474124.2015.1007955
|
| 10 |
Nilanka Perera, Jegarajah Indrakumar, Waruni Vijitha Abeysinghe, Vihangi Fernando, W. M. C. K. Samaraweera, Jayamal Sanjaya Lawrence. Non alcoholic fatty liver disease increases the mortality from acute coronary syndrome: an observational study from Sri Lanka. BMC Cardiovascular Disorders 2016; 16(1) doi: 10.1186/s12872-016-0212-8
|
| 11 |
Amir Mari, Tawfik Khoury, Helal Said Ahmad, Fadi Abu Baker, Anas Kadah, Wisam Sbeit, Rinaldo Pellicano, Mahmud Mahamid. The association between non-alcoholic fatty liver disease and valvular heart disease. Minerva Cardioangiologica 2020; 68(1) doi: 10.23736/S0026-4725.19.05087-4
|
| 12 |
Marie Boyle, Quentin M. Anstee. Evidence‐based Gastroenterology and Hepatology 4e. 2019; : 523 doi: 10.1002/9781119211419.ch35
|
| 13 |
Fabio Nascimbeni, Dante Romagnoli, Stefano Ballestri, Enrica Baldelli, Simonetta Lugari, Valentina Sirotti, Valentina Giampaoli, Amedeo Lonardo. Do Nonalcoholic Fatty Liver Disease and Fetuin-A Play Different Roles in Symptomatic Coronary Artery Disease and Peripheral Arterial Disease?. Diseases 2018; 6(1): 17 doi: 10.3390/diseases6010017
|
| 14 |
Jieun Lee, Kijung Yoon, Seungho Ryu, Yoosoo Chang, Hyoung-Ryoul Kim, Christina Chan. High-normal levels of hs-CRP predict the development of non-alcoholic fatty liver in healthy men. PLOS ONE 2017; 12(2): e0172666 doi: 10.1371/journal.pone.0172666
|
| 15 |
Nicolette Veracruz, Bilal Hameed, Sammy Saab, Robert J. Wong. The Association Between Nonalcoholic Fatty Liver Disease and Risk of Cardiovascular Disease, Stroke, and Extrahepatic Cancers. Journal of Clinical and Experimental Hepatology 2021; 11(1): 45 doi: 10.1016/j.jceh.2020.04.018
|
| 16 |
Jonathan Zhi Kai Toh, Xin-Hui Pan, Phoebe Wen Lin Tay, Cheng Han Ng, Jie Ning Yong, Jieling Xiao, Jin Hean Koh, En Ying Tan, Eunice Xiang Xuan Tan, Yock Young Dan, Poay Huan Loh, Roger Foo, Nicholas W.S. Chew, Arun J. Sanyal, Mark D. Muthiah, Mohammad Shadab Siddiqui. A Meta-Analysis on the Global Prevalence, Risk factors and Screening of Coronary Heart Disease in Nonalcoholic Fatty Liver Disease. Clinical Gastroenterology and Hepatology 2022; 20(11): 2462 doi: 10.1016/j.cgh.2021.09.021
|
| 17 |
Jung Eun Lee, Yong Jae Lee, Soo Yoon Chung, Hee Woo Cho, Byoung Jin Park, Dong Hyuk Jung, Kottarappat N Dileepan. Severity of nonalcoholic fatty liver disease is associated with subclinical cerebro-cardiovascular atherosclerosis risk in Korean men. PLOS ONE 2018; 13(3): e0193191 doi: 10.1371/journal.pone.0193191
|
| 18 |
Xiao-Lin Li, Jian-Qing Sui, Lin-Lin Lu, Nan-Nan Zhang, Xin Xu, Quan-Yong Dong, Yong-Ning Xin, Shi-Ying Xuan. Gene polymorphisms associated with non-alcoholic fatty liver disease and coronary artery disease: a concise review. Lipids in Health and Disease 2016; 15(1) doi: 10.1186/s12944-016-0221-8
|
| 19 |
Tahmineh Tavakoli, Toba Kazemi, Homa Mollaei, Fatemeh Salmani, Samira Saghafi, Ensiah Sadat Mousavi, Mahyar Mohamadifard, Gholamreza Sharifzadeh. The Relationship Between the Prevalence of Non-Alcoholic Fatty Liver Disease (NAFLD) with the Severity of Coronary Artery Disease (CAD) in Patients Undergoing Coronary Artery Angiography: A Cross- Sectional Study. Iranian Red Crescent Medical Journal 2018; 20(6) doi: 10.5812/ircmj.58369
|
| 20 |
Giada Sebastiani, Keyur Patel, Vlad Ratziu, Jordan J Feld, Brent A Neuschwander-Tetri, Massimo Pinzani, Salvatore Petta, Annalisa Berzigotti, Peter Metrakos, Naglaa Shoukry, Elizabeth M Brunt, An Tang, Jeremy F Cobbold, Jean-Marie Ekoe, Karen Seto, Peter Ghali, Stéphanie Chevalier, Quentin M Anstee, Heather Watson, Harpreet Bajaj, James Stone, Mark G Swain, Alnoor Ramji. Current considerations for clinical management and care of non-alcoholic fatty liver disease: Insights from the 1st International Workshop of the Canadian NASH Network (CanNASH). Canadian Liver Journal 2022; 5(1): 61 doi: 10.3138/canlivj-2021-0030
|
| 21 |
Kevan Josloff, Jacob Beiriger, Adnan Khan, Richard J. Gawel, Richard S. Kirby, Aaron D. Kendrick, Abhinav K. Rao, Roy X. Wang, Michelle M. Schafer, Margaret E. Pearce, Kashyap Chauhan, Yash B. Shah, Gregary D. Marhefka, Dina Halegoua-DeMarzio. Comprehensive Review of Cardiovascular Disease Risk in Nonalcoholic Fatty Liver Disease. Journal of Cardiovascular Development and Disease 2022; 9(12): 419 doi: 10.3390/jcdd9120419
|
| 22 |
Taraneh Faghihi Langroudi, Habib Haybar, Saeed Alipour Parsa, Mohamad Mahjoorian, Isa Khaheshi, Mohammadreza Naderian. The severity of coronary artery disease was not associated with non-alcoholic fatty liver disease in a series of 264 non-diabetic patients who underwent coronary angiography. Romanian Journal of Internal Medicine 2018; 56(3): 167 doi: 10.2478/rjim-2018-0009
|
| 23 |
Pamila Dua, Archana Mishra, KH Reeta. Lp-PLA2 as a biomarker and its possible associations with SARS-CoV-2 infection. Biomarkers in Medicine 2022; 16(10): 821 doi: 10.2217/bmm-2021-1129
|
| 24 |
Yu Dong, Guangsen Li. Cardiac abnormalities in patients with nonalcoholic fatty liver disease. Herz 2021; 46(2): 158 doi: 10.1007/s00059-019-04855-5
|
| 25 |
Arash Gholoobi, Mehrnoosh Gifani, Aida Gholoobi, Saeed Akhlaghi, Masoud Pezeshki Rad, Vafa Baradaran Rahimi. Relationship between the prevalence and severity of non‐alcoholic fatty liver disease and coronary artery disease: Findings from a cross‐sectional study of a referral center in northeast Iran. JGH Open 2022; 6(5): 330 doi: 10.1002/jgh3.12746
|
| 26 |
Georgiana-Diana Cazac, Cristina-Mihaela Lăcătușu, Cătălina Mihai, Elena-Daniela Grigorescu, Alina Onofriescu, Bogdan-Mircea Mihai. New Insights into Non-Alcoholic Fatty Liver Disease and Coronary Artery Disease: The Liver-Heart Axis. Life 2022; 12(8): 1189 doi: 10.3390/life12081189
|